Responses

Download PDFPDF

Amniotic membrane transplantation in the management of conjunctival malignant melanoma and primary acquired melanosis with atypia
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests

PLEASE NOTE:

  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Re: Amniotic membrane transplantation and conjunctival malignant melanoma
    Dear Editor

    We would like to thank Dr Panda for the comments on our paper. We agree that amniotic membrane grafts yield excellent results in various ocular surface defects, without donor site morbidity.

    We also agree that frozen section control of excised tissue might prevent incomplete removal of a malignant conjunctival melanoma. Although we were able to totally excise this tumour in our four reported cases, we wil...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Amniotic membrane transplantation and conjunctival malignant melanoma
    • Anita Panda, MD
    • Other Contributors:
      • Rajeev Sudan, Sanjeev K Naniway
    Dear Editor,

    We read with interest the article titled "Amniotic membrane transplantation in the management of conjunctival malignant melanoma and primary acquired melanosis with atypia" by Paridaens D et al[1] and compliment the authors for bringing the important upcoming issue of Amniotic membrane transplantation (AMT) to the limelight.

    The authors described the favourable outcome of AMT for the reconstruction of su...

    Show More
    Conflict of Interest:
    None declared.